News
FOSTER CITY, Calif. & SANTA MONICA, Calif., May 15, 2025--Gilead Sciences, Inc. (Nasdaq: GILD) will present more than 20 abstracts across both Gilead and Kite at the upcoming 2025 American Society ...
SANTA MONICA, Calif., May 14, 2024--Kite, a Gilead Company (Nasdaq: GILD), today announced 12 abstracts from its industry-leading Chimeric Antigen Receptor (CAR) T-cell therapy portfolio at the ...
Hosted on MSN1mon
Gilead Sciences, Inc. (GILD) and Kite to Present Breakthrough Cancer Therapy Data at 2025 ASCO and EHA - MSNGilead Sciences, Inc. (NASDAQ:GILD) plans to present over 20 research abstracts—spanning both Gilead and its cell therapy unit Kite—at two major medical conferences: the 2025 ASCO Annual ...
Details on Kite cell therapy data to be presented at the meeting include: ... Presentations: Acute Lymphoblastic Leukemia Abstract #7006 (Oral) Saturday, June 1 (5:00-5:12 pm) ...
“Kite’s presentations at the 48th European Society for Blood and Marrow Transplantation (EBMT) Annual Meeting demonstrate the strength of our blood cancer cell therapy development programme,” said ...
Gilead and Kite Announce Presentation of Transformative Data in 1L Metastatic Triple-Negative Breast Cancer, Updated Results in Multiple Myeloma and Early Data From Novel Investigational CAR T ...
Gilead and Kite Announce Presentation of Transformative Data in 1L Metastatic Triple-Negative Breast Cancer, Updated Results in Multiple Myeloma and Early Data From Novel Investigational CAR T ...
FOSTER CITY, Calif.& SANTA MONICA, Calif.---- Gilead Sciences, Inc. will present more than 20 abstracts across both Gilead and Kite at the upcoming 2025 American Society of Clinical Oncology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback